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Abstract: Fetal alcohol spectrum disorder (FASD), caused by prenatal alcohol exposure, 
can result in craniofacial dysmorphism, cognitive impairment, sensory and motor 
disabilities among other defects. FASD incidences are as high as 2% to 5 % children born 
in the US, and prevalence is higher in low socioeconomic populations. Despite various 
mechanisms being proposed to explain the etiology of FASD, the molecular targets of 
ethanol toxicity during development are unknown. Proposed mechanisms include cell 
death, cell signaling defects and gene expression changes. More recently, the involvement 
of several other molecular pathways was explored, including non-coding RNA, epigenetic 
changes and specific vitamin deficiencies. These various pathways may interact, producing 
a wide spectrum of consequences. Detailed understanding of these various pathways and 
their interactions will facilitate the therapeutic target identification, leading to new clinical 
intervention, which may reduce the incidence and severity of these highly prevalent 
preventable birth defects. This review discusses manifestations of alcohol exposure on the 
developing central nervous system, including the neural crest cells and sensory neural 
placodes, focusing on molecular neurodevelopmental pathways as possible therapeutic 
targets for prevention or protection.  
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1. Introduction  
Fetal alcohol syndrome (FAS), which affects approximately 2 to 7 of 1000 live births, is a severe 
developmental deficit caused by maternal ingestion of ethanol during pregnancy. Prevalence of FAS is 
variable for different populations depending on the maternal alcohol consumption rate in the given 
population. Affected individuals exhibit a spectrum of defects including specific physical, cognitive, 
psychomotor, behavioral, and learning disabilities with identifiable facial dysmorphology. However, 
many more affected subjects are not readily identifiable by the facial features. This previously 
undiagnosed population is estimated as high as ten times that of FAS and is now categorized as fetal 
alcohol spectrum disorders (FASD) [1]. Affected individuals suffer lifelong disabilities and may 
require long-term support, and so, FASD has a huge economic and societal impact. A significant 
amount of research work was done since FAS was defined in 1973 to understand alcohol’s teratogenic 
effect during development. However, it is still not clear how alcohol consumption produces a wide 
spectrum of physical and mental disabilities. This may be due to differences in dosages, timing of 
alcohol exposure (stage-dependent and/or duration dependent) or differences in comorbid 
environmental and genetic factors. For example, some effects in FAS are greater or characteristically 
different when alcohol exposure is earlier (first trimester) than later during pregnancy, and 
experimental evidence in animal models supports these findings. This review discusses the  
alcohol-induced nervous system defects, including central nervous system, neural placodes and cranial 
neural crest cells. Progress on understanding mechanisms underlying neural teratogenesis is reviewed.  
1.1. Alcohol Induced Craniofacial Defects 
Maternal ethanol exposure, in severe cases, significantly alters craniofacial features of an 
individual. Key diagnostic anomalies include small head circumference, flat midface, short nose, 
indistinct philtrum, low nasal bridge, thin upper lip, micrognathia, short palpebral fissures and other 
defects [2,3]. Studies conducted in different animal models, particularly in mice, that recapitulate a 
similar spectrum of brain and facial malformations upon alcohol exposure provided strong evidence 
that alcohol induced these craniofacial alterations [4–8]. Pioneering work by Webster and co-workers 
demonstrated that alcohol exposure in mice on gestation day (GD) 7 or 8 was sufficient to produce 
severe facial malformations in offspring [4]. Subsequent research was directed towards understanding 
vulnerability of facial structures in developing embryos to alcohol exposure [5,7,9]. The FAS mouse 
model recapitulates craniofacial defects [5,7,10] and was shown to be remarkably similar to those of 
affected humans [2,3]. It was shown that a critical developmental window for alcohol-induced 
alteration of facial development comprised gastrulation through neurulation during embryogenesis [6]. 
The fact that alcohol produced craniofacial malformations in mice resembling those in human FAS 
patients gave investigators confidence to study alcohol’s teratogenic effects in detail using animal 
models other than rodent, like chick, Xenopus and zebrafish [8,11,12]. 
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1.2. Alcohol Induced Central Nervous System Development Defects 
The key consequences of prenatal alcohol exposure are defects in central nervous system 
development. Although reduced growth and specific minor facial malformations are most 
characteristic of FAS, the effects of alcohol on brain development are most significant because they 
lead to long-term cognitive and behavioral deficits in FAS and FASD patients. Earlier studies used 
autopsy to understand structural brain defects associated with prenatal alcohol exposure. Consistent 
abnormalities reported in different autopsy studies were microcephaly (small head) and 
microencephaly (small brain) [13]. Autopsies also reported various other abnormalities, such as cases 
of agenesis or malformation of the corpus callosum; small, poorly formed cerebellum; alobar and 
semilobar holoprosencephaly; hydrocephalus; and ventriculomegaly [14,15]. One of the mechanisms 
leading to these brain defects is believed to stem from errors in migration of neuronal and glial cells [13]. 
Various autopsy reports demonstrated extreme variability in the nature and degree of brain 
malformations in children with FAS, which led these investigators to think that there might be no 
specific pattern of neurological deficits attributable to FAS [13]. However, autopsies were done on 
limited number of fetuses, neonates or small children, and often, these individuals represented the most 
severe cases of FAS.  
The devastating influence of alcohol on brain development in less severely affected individuals 
remained unappreciated for several years. Fortunately, recent advances in medical imaging technology 
with novel computational brain image analysis techniques has transformed FASD research, allowing 
visualization of brain structures in living FASD individuals. Magnetic resonance imaging (MRI) gives 
the opportunity to study affected living individuals exhibiting physical and functional deficits across 
varying levels of severity in a non-invasive way. These studies provided new insights into the brain 
defects caused by prenatal alcohol exposure. MRI is also advantageous because it allows larger study 
sample size (than autopsy studies, for example), helping investigators do quantitative analysis, identify 
consistent findings, and examine the specific nature of alcohol’s effect on the brain. To date, numerous 
MRI studies were done on FASD patients, and those reports were extensively reviewed [15]. Similar to 
autopsy studies, MRI studies consistently demonstrated total brain volume reduction in patients [15]. 
In addition, it was frequently reported that prenatal alcohol exposed patients had reduced size in 
cerebrum, cerebellum, hippocampus, and basal ganglia (including caudate nuclei), and corpus 
callosum malformations. Moreover, MRI studies showed that although brain structural abnormalities 
are widespread, all brain structures were not affected equally. Studies that measured occipital lobe 
reported no significant changes in volume, shape and displacement. However, frontal, parietal, and 
temporal lobes showed significant changes: increased cortical thickness; decreased white and grey 
matter volumes; increased grey matter density; and other histological changes were associated with 
cerebral lobe defects in subjects prenatally exposed to alcohol [15]. More recently, developmental 
cortical thinning [16], abnormal cortical thickness alterations [17], and reduced callosal thickness and 
area specifically in the anterior third and the splenium, [18] were reported in FASD.  
Human FASD associated brain phenotypes were consistently recapitulated in the rodent central 
nervous system following prenatal ethanol exposure [5,7,19–21]. Studies on animal models showed 
that ethanol interferes in all stages of brain development, but exposure at various developmental stages 
caused distinct brain developmental abnormalities. Sulik and colleagues showed unique patterns of 
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regional brain abnormalities resulted from stage-specific ethanol exposure between GD7 and GD10 in 
mice [9,19,21,22]. At the cellular level, ethanol exposure was reported to cause a permanent loss of 
neurons; ectopic neuron formation; and altered synaptogenesis and myelinogenesis. Studies showed 
that within a given brain region, different neuronal populations exhibit different degrees of 
vulnerability to alcohol. In the cerebellum, Purkinje cells were reported to be more susceptible to 
alcohol exposure than other cell types [23–25], and among the Purkinje cells, those at the stage of 
extending dendrites were more susceptible to alcohol than more mature Purkinje cells, at later stages of 
differentiation [26]. 
Early work on alcohol-induced CNS defects focused on mechanisms underlying learning 
disabilities examined hyperactivation of GABAA receptors that triggers a neurodegenerative response, 
which is particularly sensitive during the period of synaptogenesis (in humans, this occurs during the 
last weeks of pregnancy and early postnatal development). Experiments on mouse embryos showed 
massive ethanol-induced degeneration of neurons in many parts of the brain that may play a role in 
learning, memory, sensory information processing and cognitive defects. These studies primarily 
hypothesized that neurodegenerative response to ethanol exposure could be attributed to GABA 
mimetic properties of ethanol [27]. 
Animal models and tissue-culture studies identified numerous potential mechanisms of alcohol 
induced craniofacial and brain defects. Previous experiments showed higher sensitivity during 
gastrulation stages to environmental toxin-induced birth defects, including alcohol exposure [9]. 
Experiments on zebrafish embryos treated with ethanol during gastrulation and somitogenesis showed 
changes in critical signaling molecule and transcription factor expression, including the notch ligand, 
deltaB, and the proneural gene, neurogenin1 (ngn1) (Figure 1A–J). Expression changes in ngn1 
indicate that neural specification and differentiation was delayed, including brain, spinal cord and 
cranial ganglia progenitors (Figure 1A,B). Expression of ngn1 rebounded and overshot the control 
levels at later developmental times (Figure 1C). Neural tissue convergence was also delayed, showing 
a wider neural plate after ethanol exposure in a dose-dependent manner (Figure 1D–G). Defects in 
convergence and extension cell movements during gastrulation were shown to be caused by ethanol 
exposure [28]. Reduced neural specification and differentiation could produce defects in specific 
neural structures. Cranial ganglia were examined in 30 hpf (hours post-fertilization) zebrafish after 
ethanol exposure using HuC/D antibody staining, which detects differentiated neurons. Cranial ganglia 
showed significant reduction in volume after ethanol exposure as compared to untreated controls 
(Figure 1K). This suggests that defects in cell movement and signaling during early stages of 
development may lead to more severe defects at later stages. For example, the 8th ganglion (gVIII) 
was reduced, which could lead to auditory nerve defects, as seen in FASD patients (See below). 
Figure 1. Ethanol-induced neural defects in zebrafish embryos. Zebrafish embryos were 
exposed to ethanol for various times during gastrulation and somitogenesis stages.  
(A,B) Ethanol treated and control embryos were stained by in situ hybridization (ISH) to 
detect proneural gene, neurogenin1 (ngn1) expression patterns at 8 hpf. Reduced ngn1 
expression was seen after 100 mM ethanol treatment. Black arrowhead indicates 
presumptive midbrain region. White arrowhead indicates trigeminal ganglion. Dorsal view, 
anterior to the top. (C) Quantitative-PCR detecting ngn1 transcripts at 8, 12 and 15 hpf 
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showed that ethanol reduced ngn1 expression at 8 hpf, and then, increased ngn1 expression 
at 12 and 15 hpf, as compared to control levels. Ribosomal protein rsp15 gene was used as 
an endogenous control. (D–G) ngn1 ISH at 12 hpf with increasing concentrations of 
ethanol (50–200 mM) showed neural convergence defects. White line indicates the neural 
plate width, which is wider after ethanol treatment. Dorsal view, anterior to the top. (H) 
Quantification of neural plate width demonstrates neural convergence defect. The scatter 
plot shows an increasing neural plate width after ethanol treatment in a dose-dependent 
manner. Asterisk indicates a statistically significant difference (p < 0.0001) from the 
control embryos using Student’s t-test. The position of neural tube width measurement was 
at the central point of the neural tube. (I,J) Ethanol reduced deltaB expression in 
somitogenesis stage embryos. ISH on embryos using Notch ligand, deltaB probe showed 
considerable reduction in deltaB expression in the forebrain due to ethanol exposure. Black 
arrow indicates forebrain. Lateral view, anterior to the top. (K) Ethanol reduces cranial 
ganglia development. Anti-HuC/D immunostaining of embryos at 30 hpf labels the mature 
differentiated neurons. A reduction in the volume of cranial ganglia was seen after ethanol 
treatment. White dashed lines marks gVIII; White arrowhead indicates defective gM. 
Abbreviations: gV, trigeminal; gAD anterodorsal ganglion; gVIII, statoacoustic ganglion; 
gM, middle lateral line ganglion; gP, posterior lateral line ganglion. 
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1.3. Ethanol Induced Defects in Sensory System Development  
Effects on sensory systems are among the critical neural defects that can lead to abnormalities in a 
child’s social development. Sensory defects are frequently associated with FASD, including auditory, 
visual and language deficits. 
1.3.1. Auditory Defects 
Epidemiological studies showed a close association between craniofacial dysmorphism and hearing 
deficits. These studies revealed that 83% of children with FAS had conductive hearing loss and  
28% demonstrated sensorineural hearing loss [29]. Auditory system, comprising of the outer, middle 
and the inner ear, has a dual origin of the thickened ectodermal placode and cranial neural crest cells 
(CNCC). The conductive hearing loss occurs because of problems in sound conduction by the outer or 
middle ear, and can be caused by ear infections, blockage/decreased motion of the ear ossicles or 
tympanic membrane. Sensorineural hearing loss occurs due to abnormalities or loss of sensory hair 
cells in the cochlea. Increased rates of recurrent middle ear infections potentially due to Eustachian 
tube abnormalities were also associated with craniofacial defects in children with FAS, which was 
reviewed with regards to its role in language and cognition by Cone-Wesson [30].  
Most information regarding ethanol-induced sensorineural hearing loss comes from studies on 
mouse embryos, which showed high sensitivity of otic primordium development to ethanol exposure. 
Increased cell death at the rostral border of the invaginating otic placode was observed in histological 
sections [31]. These cells later form the functional sensory cells in the inner ear and neurons of the 
eighth cranial nerve. Loss of these cells could cause sensorineural hearing loss at later stages. 
Pioneering studies by Church, M.W., 1987 [29], analyzed effects of prenatal ethanol exposure on 
auditory function, using auditory brainstem response as a measure. He found that embryonic ethanol 
exposure delayed maturation of the auditory system, and a significant number of ethanol exposed 
neonatal mice showed sensorineural hearing loss. A more recent study used the rat model to show 
maternal alcohol consumption had a dose-dependent effect on electroencephalograms obtained from 
auditory cortex in ethanol-exposed neonatal rats following acoustic stimulation [32].  
Being at risk for auditory deficits coupled with CNS defects may contribute to problems with 
speech, language and auditory learning. However, a huge gap exists in our understanding of the 
mechanisms underlying the auditory manifestations of FASD. Additional studies are needed to 
characterize critical ethanol-sensitive events in otic placode and sensory development. A potential 
mechanism could include defective and delayed neuroectoderm development. These defects, combined 
with craniofacial abnormalities, could affect normal cell and tissue interactions during various 
developmental events, resulting in abnormal auditory function. For example, ethanol-induced CNCC 
defects will also need to be studied in order to completely understand otic vesicle defects. 
1.3.2. Olfactory Defects 
Fetal alcohol exposure affects various neurodevelopmental processes, including olfactory 
development and function. Previous human epidemiological studies showed an increased risk for 
adolescent ethanol abuse was associated with fetal alcohol exposure. Studies by Youngentob and 
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colleagues using adolescent rats showed an enhanced chemosensory acceptability for ethanol in 
individuals with prenatal ethanol exposure. Their study using rats showed that prenatal ethanol 
exposure produced an enhanced olfactory preference for ethanol odor and an increased ethanol  
intake [33,34]. However, factors underlying the enhanced ethanol orosensory (taste) and/or olfactory 
(smell) acceptability after fetal alcohol exposure are not yet identified.  
The olfactory bulb is a laminated structure consisting of olfactory sensory neurons (OSNs), which 
synapse with dendrites of the glutamatergic mitral and tufted cells (M/T cells) in olfactory bulb 
glomeruli. The M/T cells comprise a majority of the olfactory tract. M/T cells are also modulated by 
inhibitory GABAergic interneurons, periglomerular and granule cells (Figure 2A). Early histological 
analysis of the rat neonate olfactory bulb showed a significant decrease in cell number in the M/T cells 
and granule cell layers (27.9% and 26.4% respectively) after ethanol exposure (Figure 2A) [35]. More 
recently, advanced high-resolution MRI scans of mouse brains showed that the region with greatest 
proportional decrease in volume after alcohol exposure was the olfactory bulb [21,36]. Odor 
discrimination between highly similar odors was also impaired in prenatal alcohol exposed mice [36]. 
Figure 2. Effects of ethanol on olfactory and optic neuroplacodes. (A) Under normal 
conditions, olfactory sensory receptors synapse on to mitral/tufted cells in the glomeruli. 
This synapse can be modulated by two types of interneurons, namely periglomerular and 
granule cells. Studies have shown a reduction in the number of olfactory sensory neurons 
(OSNs), M/T cells and granule cells after ethanol treatment. (B) Normal development of 
the optic system produces various cell types in the retina. Photoreceptors synapse on 
bipolar cells, which then synapse on retinal ganglion cells. This circuit is modulated by 
interneurons, namely horizontal and amacrine cells. Ethanol reduced the number of rod 
photoreceptors, bipolar and ganglion cells. Horizontal cell dendrite arborization was also 
reduced by ethanol exposure. Black schematic synapses indicate a simplified synapse 
circuit. Red arrows indicate effects of ethanol on cell number. 
 
To identify the olfactory developmental mechanisms disrupted by fetal alcohol exposure in more 
detail [37], gene chip experiments showed reduced expression of the metabotropic glutamate  
receptor 2 (mGluR2) gene which are expressed by the OSNs and M/T cells. Gamma-aminobutyric acid 
(GABA) B receptor 1 (GABA B1) gene expression was also decreased as a consequence of fetal 
alcohol exposure. Adrenergic receptor 1 (Adra1, highest expression density in the olfactory bulb in the 
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brain) expression was also reduced. Adra1 plays an important role in signal enhancement in OSNs.  
In addition to these neurotransmitter receptor genes, expression of many other genes involved in 
synaptic transmission, development and cell fate specification were affected by ethanol exposure. 
Their studies suggest that alcohol induced defects are two-fold: reducing number of specific cells in 
the olfactory bulb; and interrupting normal neurotransmission processes. Additional characterization of 
the olfactory bulb developmental defects are needed to understand alcohol-induced olfactory system 
defects, including systematic analysis of gene expression changes and cell death in the developing 
olfactory bulb. 
1.3.3. Ocular Defects 
FAS is associated with visual system developmental defects. Epidemiological studies showed 
association of FAS with defects in almost all parts of the eye. Severe cases had microphthalmia, 
coloboma and cataract. Milder defects were also seen in FAS/FASD patients, including strabismus, 
high refractive errors and reduced visual acuity. Ninety six percent of children suffering from FASD 
showed ophthalmological defects [38]. Human epidemiological studies showed persistently poor 
vision that remained unchanged even in follow-up measurements. The children with FAS also 
frequently display optic nerve hypoplasia and abnormal electroretinograms. 
The eye is an extremely sensitive indicator of prenatal abnormalities induced by teratogen exposure, 
and assessment of ocular defects is relatively easy, clinically accessible and well defined. Retinal 
development is well characterized in most animal models. Following evagination from diencephalon, 
retinal developmental signaling and cell specification events are initiated by inductive signals from the 
optic stalk. Interactions with the ectoderm (lens placode) and the perioptic mesenchyme (derived from 
CNCCs) help orchestrate eye development. Specific signaling events propagate the neurogenic wave 
of differentiation, and lamination of retinal cell types occurs as the tissue matures. Photosensory 
receptors of the retina (the rods and cones) synapse on interneurons, namely bipolar and horizontal 
cells (Figure 2B). These neurons then synapse on amacrine and ganglion cells. The retinal ganglion 
cells form the optic nerve and project their axons to retinorecipient brain regions for further processing 
of the visual stimuli (Figure 2B). Müller glial cells are the astroglia of the retina. These cells not only 
maintain ionic homeostasis but may also represent a stem cell population within the retina. 
Initial studies using various vertebrate animal models documented significant reduction in ganglion 
cell number and changes in optic nerve axon structure, specifically showing delayed or defective 
myelination following ethanol exposure [38]. This also correlated with defective or delayed 
gliogenesis seen in embryos after ethanol exposure. Subsequent studies dissected mechanisms 
underlying ethanol-induced retinal defects. Clinical examinations identified that scotopic 
electroretinograms (ERGs) showed more deficiencies than photopic ERG [39]. Experimental evidence 
supporting this finding showed reduced rhodopsin expression in mouse embryos exposed to ethanol [40]. 
Effects of ethanol on photoreceptors and their ERGs were dose-dependent [41]. Using zebrafish as  
a model, Bilotta et al. [42], showed that a significant reduction in eye diameter and optomotor response 
in fish treated with ethanol during somitogenesis (12–24 hpf). This developmental period includes 
optic primordium specification and neurogenesis events. Treatment during time windows before or  
after 12–24 hpf did not cause as severe defects as those produced by treatment during 12–24 hpf.  
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Also, higher ethanol concentrations during this sensitive period induced severe lamination defects and 
cyclopia [43]. The authors also suggested that retinal defects may be caused by impaired migration of 
prechordal plate during retinal morphogenesis because mutants showing similar eye defects exhibit 
prechordal plate migration defects [8]. Experiments on Xenopus embryos showed that ethanol 
exposure during early development caused abnormal expression of eye morphogenetic genes such as 
Pax6 and Tbx3, which could result from increased in sonic hedgehog (shh) expression levels [44]. 
Studies on zebrafish showed that the presence of ethanol during retinal neurogenesis (24–48 hpf) 
induced persistent microphthalmia caused by increased cell death in the retina and lens as compared to 
untreated embryos [45]. A significant reduction in the number of each retinal cell types including 
photoreceptors and ganglion cells was seen (Figure 2B). The investigators designed rescue 
experiments to target signaling pathways that may be affected by ethanol, including shh and retinoic 
acid (RA) signaling. Their experiments showed that ethanol mediated defects were not rescued by 
these treatments, suggesting that retinal defects were caused by alternative pathways during this 
developmental period. However, photoreceptor differentiation could be rescued by RA treatment. 
Transmission of visual signals from photoreceptors occurs via the interneurons, namely the bipolar 
and horizontal cells. Studies on mouse embryos showed significant, persistent and dose-dependent 
reduction in the number of bipolar cells (PKC-α positive) [46]. Other experiments showed significant 
reduction in the dendritic receptive field of horizontal cells. However, since bipolar and horizontal 
cells are among the last cell types to differentiate and cell types that continue differentiation 
postnatally, defects in bipolar and horizontal cells may be secondary effects of earlier defects in the 
retina. To summarize, ethanol induced defects on retinal development are dose and time dependent, 
leading to a severe, persistent defects in the structure and function of all retinal cell types. Additional 
experiments are necessary to understand specific signaling mechanisms underlying retina and  
lens defects. 
Various cell types that comprise the above-described sensory systems show severe reduction in 
numbers and functional defects after ethanol exposure. Ethanol-induced defects on the precursor cells 
of the sensory systems, including the placode and CNCCs, are not clearly understood. Systematic 
examination of developmental defects in sensory systems and evaluating mechanisms underlying these 
defects, such as delayed or defective signaling between the placode and neuroectodermal tissues, and 
CNCC cell death, will be insightful in understanding associated psychomotor defects in FASD patients 
and to evaluate therapeutic interventions. 
1.4. Ethanol and Neural Crest Cells 
Studies using mouse and chick showed that alcohol exposure at specific stages of early embryonic 
development did not equally affect all cells within the embryo. Alcohol administration during 
gastrulation and neurulation produced a major insult to the anterior neural plate, and in particular, the 
population of cells destined to give rise to brain and facial structures, CNCC [6,47–50]. These cells 
originate from the dorsal neural tube following its closure and migrate to specific locations [51]. 
Neural crest cells differentiate and form diverse structures, including majority of the head connective 
and skeletal structures; nerves; pigment cells; aorticopulmonary septum and conotruncal cushions of 
heart; enteric ganglia; and sensory and sympathetic ganglia [52]. CNCC also contribute to various 
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parts of sensory organs, such as cartilage in the middle ear and periocular mesenchyme surrounding 
the retina, which later forms the corneal epithelium, ciliary body and sclera. CNCCs give rise to 
specific features that are affected in FAS patients. Studies of alcohol induced cell death have been 
extensively reviewed [50]. Those findings suggested that prenatal alcohol exposure induced apoptotic 
elimination of premigratory and migratory neural crest cells. Alcohol exposure at distinct 
developmental window differentially affected the CNCC death [6,47,50]. Researchers have 
extensively investigated mechanisms that could trigger the CNCC death. 
2. Potential Mechanisms Underlying Ethanol-Induced Neural Defects: Possible  
Therapeutic Targets 
Numerous molecular mechanisms underlying ethanol-induced defects in human patients were 
hypothesized and studied experimentally in rodents and other vertebrates. It is likely that ethanol 
toxicity for the embryo proceeds by more than one mechanism, and primary targets and secondary 
effects of ethanol toxicity still need to be identified. 
2.1. Ethanol-Induced Nutritional Deficiencies 
Vitamin deficiencies were linked to a number of diseases, which are particularly prevalent in 
populations of low socioeconomic conditions. Alcohol consumption also aggravates malnutrition by 
interfering with the absorption, digestion and utilization of nutrients consumed. Chronic alcoholics 
tend to have a poor nutritional status and vitamin deficiencies, including vitamins A, B-complex, E and 
folic acid [53]. Thus, a potential contributing factor causing an increased FASD incidence in lower 
socioeconomic populations is severe nutritional deficiency, aggravated further by chronic alcohol 
consumption. 
2.1.1. Retinoic Acid  
Retinoic acid (RA) is a morphogen, which plays a critical role in the vertebrate nervous system and 
limb morphogenesis. RA gradients are critical in the establishment of anterior posterior axis of the 
nervous system [54]. Vitamin A (retinol) is oxidized to RA in a developing embryo. The RA 
morphogen gradient is tightly controlled in specific tissues by regulating gene expression of 
alcohol/aldehyde dehydrogenases (ADH/ALDHs) and various RA degradation enzymes. RA is 
membrane permeable. It binds nuclear retinoic acid receptors and activates transcription of specific 
genes in target tissues. Reduced RA signaling due to mutations in RA synthesizing enzymes or due to 
vitamin A-deficient diets during pregnancy can produce complex developmental phenotypes that 
resemble FAS-associated defects. 
Enzyme kinetics of isolated human liver ADHs showed that ethanol competitively inhibits retinol 
oxidation [55]. Presence of ethanol during embryonic development may reduce RA in target tissues 
due to the competition between ethanol detoxification and vitamin A metabolism. The resulting deficit 
in RA signaling may produce embryonic malformations. Many studies have examined the inhibition of 
RA synthesis as a potential mechanism underlying the FASD phenotype [56,57]. RA rescue 
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experiments were also used to test its role in ethanol-induced defects during gastrulation, ocular and 
limb development. 
Studies on Xenopus and zebrafish embryos showed dramatic rescue of ethanol-induced phenotypes 
by supplementing with low concentrations of various retinoids [58–60]. RA rescued ethanol-induced 
effects, including anterior-posterior neural axis length, craniofacial and ocular abnormalities. 
Experiments using Xenopus embryos showed a strong similarity between the defects induced by  
high ethanol concentrations and those induced by combined treatment of low ethanol concentration 
and RA signaling inhibitor such as DEAB or retinaldehyde dehydrogenase (RALDH) knockdown.  
RA-responsive hox gene expression was suppressed at similar levels using either high ethanol 
concentration or low ethanol concentration plus RA signaling inhibitor [59], suggesting that activation 
of RALDH activity can compensate, in part, for the deleterious effect of ethanol. Rescue experiments 
using low concentrations of RA or RALDH overexpression could restore most ethanol-induced 
defects. Using zebrafish, Marrs et al. [57], showed that ethanol exposure during gastrulation and 
somitogenesis caused reduced epiboly, short body length and craniofacial defects (Figure 3D). RA 
supplementation (1 nM) rescued most of these defects. However, RA plus ethanol treated embryos 
showed cardiac edema (Figure 3E, black arrow). These experiments strongly suggested that many but 
not all developmental malformations observed in FASD were caused by reduced concentrations of RA 
during embryonic development. 
Figure 3. Retinoic acid or folic acid supplementation with ethanol during zebrafish 
embryogenesis significantly rescues ethanol induced morphological defects. (A–C) Lateral 
view of live images showed normal embryonic morphology in the control, 1 nM RA and 
75 μM FA treated embryos at 52 hpf. (D) Ethanol treated (150 mM) embryos exhibited 
shorter body, small eye, and heart edema at 52 hpf. (E) Ethanol (150 mM) and  
RA (1 nM) co-treated embryo showed rescue of ethanol-induced small eye and short body 
length defect, but not the pericardial edema. (F) Ethanol (150 mM) and FA (75 μM)  
co-supplementation rescued most of ethanol-induced defects including shorter body, small 
eye, and heart edema. Ethanol plus FA supplemented embryo (F) showed normal 
morphology at 52 hpf. Black arrow indicates heart; white arrow indicates eye; arrowhead 
indicates posterior end of the embryo. Based on [61]. 
 
However, reports by Kane et al. [61] indicate elevated physiological RA levels after ethanol 
exposure at multiple loci in the embryonic and adult mouse tissues, particularly brain tissues.  
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These experiments suggest that tissue-specific increases in RA may contribute to the etiology of 
ethanol-induced defects. In another study, mechanisms underlying ethanol-induced retinal defects were 
dissected. They found that alcohol treatment during retinal neurogenesis (24–48 hpf) produced ocular 
manifestations, including defective retinal ganglion cell and photoreceptor differentiation. RA rescued 
photoreceptor differentiation, but did not rescue microphthalmia or ganglion cell defects [62]. 
The use of RA as a therapeutic is limited because it is a known teratogen. Overexposure to RA can 
disrupt the morphogen gradient and cause embryonic malformations. From a therapeutic perspective, a 
safer and more effective agent is needed to prevent or reverse potential ethanol-induced defects. 
2.1.2. Folic Acid 
Folate has several important roles in multiple metabolic pathways. It is an essential cofactor in 
nucleic acid synthesis. Conversion to tetrahydrofolate (THF) involved in one carbon metabolism, is an 
important pathway leading to epigenetic changes by the transfer of methyl groups onto DNA and 
histones, which regulates gene expression. Folate also plays an important role as an antioxidant.  
Its deficiency during pregnancy may cause neural tube closure defects and other severe fetal 
malformations. Supplementation of FA in pregnant mothers lowers the rate of neural tube closure 
defects, congenital heart defects and cleft lip/palate. Folate may rescue several impaired signaling 
mechanisms, including Wnt/β-catenin signaling, epigenetic and oxidative stress mediated defects. 
Prenatal ethanol exposure produces impaired developmental signaling, oxidative stress and epigenetic 
regulation, and reports suggest rescue by folic acid treatment. 
Normally an essential part of nucleotide synthesis and repair, FA deficiency can have wide ranging 
consequences. Ethanol consumption interferes with folate absorption; inhibiting its metabolism; 
increasing excretion of FA; reducing serum and hepatic FA levels; and reducing expression of various 
folate metabolizing enzymes [63,64]. Due to the involvement of folate in epigenetic events like DNA 
methylation, ethanol induced folate deficiency was shown to decrease availability of the methyl donor, 
S-adenosyl methionine (SAM) [65]. Hence, FA deficiency may change the epigenetic profile of the 
developing embryo, leading to changes in gene expression and developmental defects. 
Studies in mouse and chick embryos showed that ethanol exposure produces neural tube closure 
defects like those that result from FA deficiency [31,66]. A clinical study showed a significant 
reduction in fetal-to-maternal folate ratios in pregnant women after ethanol exposure, indicating 
reduced folate transfer from the mother to the developing embryos [67]. This data was supported by  
a significant reduction in folate levels in blood from babies born to alcohol abusing mothers, as 
compared to control groups. They proposed that antioxidant activity was diminished due to defective 
maternal-to-fetal folate transfer, causing increased ethanol-induced oxidative stress. A study of mouse 
embryos suggested that FA has a protective role after ethanol treatment through a microRNA 
(miRNA) mediated mechanism [68]. Investigators showed elevated levels of specific miRNA  
(miR10a and miR10b) in ethanol exposed mouse embryos, which could be suppressed by FA 
supplementation [68]. Using mouse and chick models, Linask and colleagues showed that FA 
supplementation prevented ethanol induced heart developmental defects [69]. Using zebrafish,  
the Marrs laboratory showed that FA supplementation significantly rescued body length defect,  
small eye, and cardiac edema seen in embryos exposed to ethanol alone (Figure 3D,F). Additional 
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studies are needed to determine the effects of ethanol induced FA deficiency on specific 
neurodevelopmental processes. 
2.1.3. Choline 
Choline is an essential nutrient, grouped with vitamin B-complex, which plays critical roles as  
a precursor to the neurotransmitter acetylcholine and various essential cell membrane constituents, 
including phosphatidylcholine and sphingomyelin. Choline is also thought to influence DNA 
methylation by serving as a methyl donor and thus regulating gene expression. Like folate, choline is 
necessary during fetal development, and choline deficiencies lead to severe neural tube defects and 
CNS dysfunction [70]. Choline supplementation in animal models throughout pregnancy was shown to 
provide protective and beneficial effects on CNS and behavioral development, and these studies 
showed that choline supplementation increased neuronal proliferation and differentiation, especially in 
hippocampus and septum. 
Being an essential nutrient, choline deficiency leads to a wide spectrum of defects. Ethanol-induced 
deficiency of choline may also be responsible for several behavioral deficits. Its deficiency may reduce 
acetylcholine production and produce long-term learning and memory deficits. Choline deficiency may 
also reduce DNA methylation, changing epigenetic events that lead to a wide spectrum of defects. 
Initial experiments showed that choline supplementation could significantly attenuate severity of 
ethanol-induced behavioral defects in a FASD model, but not morphological defects [71]. Then, these 
investigators dissected specific behavioral parameters, including spontaneous alternation, spatial 
learning and working memory. These studies tested for hippocampal-based learning and memory. 
Spontaneous alternation, which tests for spatial memory measuring natural exploratory and foraging 
behavior using the T-maze setup, was significantly affected in ethanol treated offspring and was 
partially rescued by choline supplementation [72]. The effect of ethanol on spatial and working 
memory was not as severe, but these defects were considerably improved following choline 
supplementation. This effect could result from the alteration in ratios of specific cholinergic receptors 
after ethanol treatment, which could be rescued by choline [73]. To further examine the mechanism 
underlying choline rescue, Otero and colleagues studied changes in average tissue DNA methylation 
after ethanol and choline treatments, and compared these to untreated controls. Ethanol treatment 
caused global DNA hypermethylation in prefrontal cortex and hippocampal brain regions, which was 
reduced significantly by choline supplementation [74]. Additional research is needed to identify 
mechanisms underlying choline rescue of specific behavioral parameters and DNA methylation. 
Prenatal and postnatal choline intake was reported to be beneficial for enhancing cognitive 
functions and was shown to change CNS structure and function by increasing neuronal proliferation 
and differentiation. It is an excellent candidate for preventive and therapeutic treatment to alleviate 
behavioral and other defects due to prenatal ethanol exposure. However, effects of ethanol on choline 
uptake and metabolism are not known. Additional research is needed to determine whether choline 
deficiency is underlying ethanol-induced birth defects and whether choline supplement can protect or 
restore brain development or function. 
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2.1.4. Vitamin E 
Vitamin E (VE), α-tocopherol, is a powerful antioxidant and is known to offer protection from 
ethanol induced neurotoxicity [75–77]. During pregnancy, VE deficiency causes several 
developmental abnormalities and behavioral deficits, which may cause oxidative stress of the rapidly 
growing embryo [78]. Among the many mechanisms thought to contribute to the etiology of FASD, 
ethanol induced apoptosis caused by reactive oxygen species (ROS) is well supported and studied. 
Natural VE can protect against ethanol-induced neurotoxicity in a rat hippocampal cell culture  
FAS model by preventing lipid peroxidation and preserving membrane integrity, perhaps by 
scavenging damaging free radicals. Experiments by Heaton et al. [79] showed that VE 
supplementation significantly stimulated secretion of neurotrophic factors such as BDNF, NT-3 and 
upregulation of anti-apoptotic molecules including Bcl-2, Bcl-xl and pAkt (Figure 4). These effects 
could promote cell survival and reduce toxic ROS [79]. 
VE supplementation consistently showed a reduction in ethanol-induced cell loss within certain 
brain structures [75]. However, these VE treatments failed to rescue behavioral deficits.  
Ethanol-induced VE deficiency and VE enhanced neuronal survival are not well understood. 
2.2. Ethanol-Induced Oxidative Stress: ROS Generation and Cell Death 
Ethanol-induced neurotoxicity was primarily attributed to ROS-induced cellular damage. Together 
with nutrient deficiencies and other effects, ethanol can increase the production of ROS, which are 
coupled with decreased levels of antioxidant defenses, redox imbalance and oxidative damage to 
lipids, proteins, and DNA. This oxidative stress can contribute, in part, to the neurodegeneration 
effects observed in FASD. This was extensively reviewed by Brocardo et al. [80]. 
Studies on cerebellar granule cell cultures were used to dissect the pathways upstream and 
downstream of ethanol-induced ROS production (Figure 4). Ethanol-exposure induced pro-apoptotic 
protein upregulation and decreased anti-apoptotic protein expression, mitochondrial release of 
cytochrome c, and, finally, triggering cell death (Figure 4). Some studies support that ethanol-induced 
neurotoxicity also interferes with expression of neurotrophic factors (e.g., BDNF, NT-3 [79]), and 
reduced growth factor expression induce neuronal cell death. This interference in neurotrophic factor 
expression can be a result of reduced vitamin E, which is involved in stimulation neurotrophic and 
anti-apoptotic factors secretion (see above), a direct reduction in expression by ethanol, or a secondary 
pathway yet to be elucidated. Numerous exogenous antioxidants, including superoxide dismutase 
(SOD), catalase, VE, N-acetylcysteine and lipoic acid, significantly decrease apoptosis in  
ethanol-exposed embryos [81–83]. Many nutritional antioxidants, including various vitamins (C, E), 
folate and flavonoids showed protective effects (Figure 4) by reducing ethanol-induced oxidative  
stress [84]. Activation of key antioxidant proteins, such as Nrf-2 (Figure 4) by chemical gene 
activators like 3H-1,2 dithiole-3-thione (D3T) were also tested for their neuroprotective effects on 
ethanol exposed embryos [85]. Providing neurotrophic support, including BDNF, VE and  
PPAR-γ agonists [86], were studied as viable therapeutic targets, and antioxidant compounds also 
provide a potential therapeutic approach, which can be tested in ethanol-treated animal models. In 
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summary, antioxidants may be effective, alone or in combination with other therapeutic agents to 
mitigate neural defects and behavioral deficits observed in individuals affected with FASD. 
Figure 4. Proposed mechanism for ethanol-induced oxidative stress-mediated cell death. 
Ethanol can act as an oxidant by inducing the production of reactive oxidative species 
(ROS) during ethanol degradation. ROS can induce translocation of pro-apoptotic proteins, 
BAX/BAK to the mitochondrial membrane leading to disruption of membrane integrity. 
The resulting cytochrome c release induces caspase cascade, leading to apoptosis. 
Cytochrome c release also causes increased superoxide formation and enhanced ROS 
production. This leads to protein oxidation, lipid peroxidation and DNA damage, which 
can enhance apoptosis induction pathways. Vitamin E and neurotrophic factors such as 
BDNF and NT3 are known to inhibit BAX/BAK translocation and apoptosis. Anti-
apoptotic proteins such as Bcl-2 and Bcl-xl are also affected by to reduced vitamin E (VE) 
and BDNF. Ethanol reduces vitamin E and neurotrophic factors, which in turn affect Bcl-2 
and Bcl-xl. Together, ethanol promotes BAX/BAK translocation to mitochondrial 
membrane, leading to apoptosis. Key genes like Nrf-2 regulate antioxidant enzymes, 
including superoxide dismutase and catalase. This is reduced in ethanol-treated cells. Black 
lines/arrows indicate normal pathway for cell death, and red lines/arrows indicate ethanol-
induced changes, increase or decrease. Green boxes indicate therapeutic targets that have 
been tested for rescue of oxidative-stress mediated cell death. 
 
2.3. Cell Death 
In addition to ROS-mediated cell death, other studies showed specific pathways participate in 
apoptosis of CNCCs (Figure 5). A study showed CNCC cell death following ethanol exposure 
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occurred via a ceramide-induced, caspase-3-mediated pathway [87]. These investigators showed an 
increased conversion of sphingomyelin (ceramide precursor molecule) to ceramide in ethanol-treated 
CNCC cultures. Their results suggest that defects in lipid metabolism, like sphingomyelin.  
The investigators propose that this can lead to reduced sphingomyelin dependent lipid-rafts in the 
neural-tube associated cells leading to folate-binding protein 1 (folbp-1) malfunction and resulting in 
folate deficiency. The investigators also proposed that ethanol treatment reduced levels of one carbon 
metabolism pathway intermediates, such as SAM, phosphatidylcholine and sphingomyelin. One 
carbon metabolism functions that heavily rely on folate and vitamin B complex were affected. 
However, additional detailed examination is required to determine the players of this pathway. 
Figure 5. Proposed mechanisms of ethanol-induced cranial neural crest cell death. Ethanol 
exposure can induce the caspase cascade, which leads to apoptosis of the cranial neural 
crest cells (CNCCs) via two known mechanisms. Ethanol can activate G-protein coupled 
receptors, activating phospholipase C, which breaks down phosphatidylinositol-bisphosphate 
to IP3 and DAG. IP3 mediated release of intracellular calcium stores leads to increased Ca+2 
dependent kinase activation. Calmodulin and CamKII activation leads to phophorylation 
and proteolysis of β-catenin, which affects gene expression and CNCC apoptosis. 
Reducing β-catenin degradation is a potential therapeutic target, and kinase inhibitors for 
CamKII and GSK3β (canonical Wnt inhibitor) have been tested (red boxes).  
Ethanol-induced production of ceramide from sphingomyelin is another potential 
mechanism that leads to the malfunction of folbp-1, folate binding protein-1, and 
contributing to FA deficiency. This can lead to increased CNCC death. Supplementation 
with FA can potentially rescue CNCC death (green box). Based on studies from Smith and 
colleagues [80–82,84]. Dotted line indicates possible interaction between canonical and 
noncanonical Wnt signaling pathways. 
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Investigators proposed calcium-mediated β-catenin destabilization as an underlying mechanism for 
CNCC apoptosis (Figure 5) [88,89] Studies on developing chick embryos suggest ethanol exposure 
induced activation of the GPCR, Gαi/o, and elevated IP3 levels via activation of Phospholipase Cβ.  
IP3-mediated release of calcium stores could directly affect non-canonical Wnt/Ca2+ signaling 
pathway. Evidence showed destabilization of β-catenin, reduction in β-catenin-mediated 
transcriptional activation and initiation of apoptosis after ethanol exposure in the neural folds. The 
hypothesis that ethanol exposure interferes with β-catenin function and induces apoptosis is consistent 
with the previously proposed role of β-catenin in CNCC survival. These investigators also suggest that 
ethanol may act through the downstream effectors of the non-canonical Wnt pathway, including 
calcium mediated kinases and proteases like CaMKII, PKC and calcineurin-NFAT. These enzymes 
could induce ubiquitination and proteolytic degradation of β-catenin [90].  
A small molecule screen showed that calmodulin inhibitors significantly enhanced CNCC survival 
in ethanol-treated embryos [91]. These studies showed that CaMKII activation leads to alcohol 
neurotoxicity. CaM kinases are targets of activated calmodulin, and inhibitors of CaM kinases were 
able to rescue CNCC death. CaMKII activation may cause ubiquitination and proteolytic destruction of 
nuclear β-catenin, which negatively feeds back on cell survival gene expression in CNCCs. β-Catenin 
degradation can result from CaMKII activation directly or by disrupting the critical balance between 
non-canonical Wnt and canonical Wnt signaling. This disruption could help explain ethanol-induced 
effects on β-catenin stability, which affects canonical Wnt functions like cell survival, proliferation 
and migration. As a potential therapeutic tool for canonical Wnt signaling, GSK3β small molecule 
inhibitors, which stabilize nuclear β-catenin, could be tested for their ability to prevent CNCC 
apoptosis and preserve CNCC development during embryogenesis. 
In summary, there are several potential targets for preserving CNCC survival. To target β-catenin 
ubiquitination and proteolysis, small molecule inhibitors of GSK3β and CaMKII may provide potential 
therapeutics for testing [92]. 
2.4. Epigenetics 
Epigenetics are heritable, and potentially reversible, changes in the functionally diverse cells of  
a multicellular organism, which governs the compaction and folding of chromatin structure mainly  
by covalent modifications on DNA and histones. Epigenetic mechanisms regulate gene expression at 
the level of transcription by modulating the accessibility of gene promoter regions to the 
transcriptional machinery. 
The chromatin modifications include DNA methylation, histone posttranslational modifications 
(methylation, phosphorylation, acetylation and others). The interplay between DNA methylation, 
histone modifications and a variety of chromatin modulating complexes regulates chromatin folding, 
and thus, gene expression. Epigenetic modifications are produced by specific enzymes, including DNA 
methyltransferases (DNMTs), histone methyltransferases (HMTs), histone acetyltransferases and 
deacetylases (HATs and HDACs respectively). 
Several nutritional factors regulate the epigenetic profile, including dietary supplements like FA, 
choline, vitamin B12 and other nutrients. Studies suggest that environmental factors, like alcohol and 
drugs, have a negative impact on epigenetic modifications [93]. Epigenetic modifications induced by 
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drug exposure in utero were associated with long-lasting behavioral phenotypes, including 
hyperactivity and psychiatric disorders in children [94]. 
Ethanol interferes with components of the one carbon metabolism pathway, including folate, 
choline (a derivative of homocysteine) and SAM (methyl donor). Disrupting one carbon metabolism 
can lead epigenetic alterations and global changes in epigenetic profiles. Epigenetic changes induced 
by embryonic ethanol exposure were recently reviewed [95,96]. Pregnant mice treated with ethanol 
showed significant embryo hypomethylation [97]. Classic experiments also showed significantly 
reduced offspring growth due to preconceptional (60 days prior through conception) maternal or 
paternal alcohol exposure, indicating that directly exposing offspring to alcohol is not necessary to 
induce developmental abnormalities. Thus, epigenetic changes in the germ line could be an additional 
contributing factor in FASD. 
Mechanistic studies in mouse models showed that prenatal ethanol exposure increased embryo 
DNA methylation. In these studies, investigators used epigenetically sensitive strains of mice 
expressing reporter yellow pigment (Agouti viable yellow, Avy mice). Neonates born after ethanol 
exposure showed decreased expression of pigment, indicating suppression of pigment gene expression 
due to DNA hypermethylation [98]. However, whether these ethanol induced epigenetic changes were 
site-specific was not studied. Altered DNMT expression levels were seen in sperm cells of male rats 
exposed to ethanol [99]. Ethanol-induced alterations DNA methylation profile during early neurulation 
in developing mouse embryos and neural stem cell cultures were also observed. High-throughput 
methyl DNA microarray analysis identified specific DNA methylation changes associated with 
dysregulation of neural stem cell migration and differentiation program after ethanol exposure [100]. 
These experiments also identified global epigenetic changes in and around promoter regions due to 
ethanol exposure, which correlated to growth retardation in developing embryos [101]. This suggests 
that alcohol exposure prevented normal DNA methylation progression, a critical sequence of events 
during differentiation of neural cells [100]. The DNA methylation program during development from 
blastocysts, during gastrulation, and through neurulation utilize 5methylcytosine (5mC) and 
5hydroxylmethylcytosine (5hmC) changes in DNA, which are spatiotemporally regulated [93]. This 
was also recently documented in the developing nervous system [102]. Alcohol affects on 
spatiotemporal progression of the DNA methylation occurred in the neural tube [103] and 
hippocampus [102]. Inhibiting DNA methylation produced similar growth retardation effects in the 
embryos during neurulation [103]. 
In addition to the DNA methylation, studies on neural stem cells showed that histone modifications 
including tri-methylated histone 3 on lysine 27 (3me-H3K27), di-methylated histone 3 on lysine 4 
2me-H3K4, and acetylated H4 (Ac-H4) are closely tied to the migration of neural stem cells and their 
differentiation [104]. Recent experiments on mouse embryos showed that ethanol exposure enhanced 
transcriptional activation of G9a, a histone methyltransferase (HMT), which produces the H3 
modifications 2me-H3K9 and 2me-H3K27. These modifications led to H3 degradation and 
neurodegeneration. Pharmacological inhibition of G9a activity before or during ethanol exposure could 
restore H3 levels and rescue neural cell survival [105]. In another study, choline supplementation 
during ethanol treatment could rescue expression levels for DNMTs and histone-modifying enzymes [106]. 
Choline deficiency was previously shown to alter G9a activity. Quantitative PCR studies showed 
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rescue of G9a and Setdb1 (HMTs) expression by choline supplementation. Choline supplementation 
could also rescue DNMT expression levels in ethanol-treated mouse embryos. 
One potential mechanism underlying ethanol-induced disruption of one-carbon metabolism could 
be a direct effect on epigenetic regulators. Another possibility can involve ethanol-induced effects on 
gene expression via intermediate mechanisms, which could include epigenetic modulating factors. 
Experiments on early zebrafish embryos showed changes in expression levels of specific epigenetic 
modulators [28]. Changes in the epigenome greatly alter gene expression profiles, which ripples down 
to various developmental or physiological signaling disruptions. Effects of ethanol on DNA and 
histone methylation pathways are not clearly understood, but these effects appear to be very central to 
the ethanol-induced defects as illustrated by the rescue effects of various epigenetic modifiers. 
2.5. Non-Coding RNA 
In recent years, non-protein-coding regions of the genome were shown to play a critical role in 
regulating normal developmental processes, physiology and disease [107]. Roles for noncoding RNA 
(ncRNAs) especially micro-RNA (miRNA) were studied as regulators of various biological processes, 
including cell cycle, fate specification, differentiation, and cell death. These miRNAs genes are 
transcribed by RNA polymerase II, processed in the nucleus and assembled into RNA-induced 
silencing complexes (RISC) in the cytoplasm. These complexes inhibit gene expression by binding to 
mRNAs and inhibiting translation. Various diseases were linked to changes in miRNA expression 
including cancer, neurodegenerative and metabolic diseases. Although involvement of miRNA in FAS 
model was predicted [108], only a few studies have focused on specific miRNA dysregulation due to 
ethanol exposure and its role in manifestation of FASD. 
Initial cell culture studies examined specific neuronal miRNAs, showing that some miRNA 
expression levels changed after ethanol treatment. Ethanol caused some miRNAs to be highly 
expressed and others to be downregulated [109]. Ethanol-induced upregulation of miRNA-335, -21, -9 
and -153 could disrupt neuronal specification and differentiation process. Jag-1, a notch ligand is 
activated by coordinated suppression of miRNA-335, -21 and -153. A proneural gene involved in 
neuronal maturation, Evalv2, was upregulated by suppression of miR-335, -153 and -9. These findings 
suggest that altered miRNA gene expression induced by prenatal ethanol is a mechanism for neuronal  
birth defects. 
Wang et al. [68] showed significant upregulation of miR-10a and -10b and other miRs in ethanol 
treated mouse embryos. miR-10a and 10b are located adjacent to a Hox gene cluster and target Hoxa1 
expression, inhibiting its translation in ethanol treated embryos. These investigators also found that 
inhibition over Hoxa1 translation was rescued by FA supplementation in a dose-dependent fashion, 
without altering Hoxa1 mRNA levels. This strongly suggests a post-transcriptional or translational 
mechanism (like miRNA-mediated) of gene expression regulation. Microarray analysis on zebrafish 
embryos treated with high and low doses of ethanol showed effects on a several miRNAs [110]. 
Different sets of miRNAs were affected by different doses of ethanol in a complex pattern. These 
results also showed upregulation of miR-9, which contradicted the earlier study. Together, these 
findings suggest that miRNA genes were differentially affected by ethanol depending on concentration 
and the tissue type. Predicted targets for many of the affected miRNA genes are neural developmental 
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signaling mechanisms. Additional research is needed to understand the complex mechanisms 
underlying ethanol-induced changes in miRNA expression and to identify subtypes of miRNAs that 
are particularly sensitive to ethanol exposure 
3. Conclusions 
Molecular mechanisms underlying ethanol-induced defects require close examination to identify 
specific targets of ethanol toxicity during development. These primary targets may lead to various  
cell-specific and tissue-specific changes. For instance, early ethanol exposure caused CNCC apoptosis, 
and CNCCs are involved in multiple organ cell specification and differentiation events. Interrupting 
cell signaling and tissue interactions could lead to defective cellular structures, gene expression, tissue 
architecture and organ function. However, most studies focusing on specific defects in  
a developing or mature organ fail to examine lineages of precursor cell types and their defects.  
In addition to molecular mechanisms, genetic, nutritional and environmental factors may alter the 
severity of ethanol-induced defects in the developing embryo.  
Mechanisms outlined above are not independent of each other, suggesting that multiple ethanol 
targets produce a complex interplay between pathways, which cascade down to a myriad of changes at 
DNA, RNA and protein levels. If true, then combination of therapeutic agents may be necessary to 
mitigate the FASD deficits. However, there may be nutritional or developmental pathways that are 
centralized and may provide key support for the developing embryo. New studies are needed to define 
and maximize rescue effects to prevent neural damage. 
Many of the proposed interventions mentioned above, like nutritional supplements, are preventive 
measures that may reduce the severity of ethanol-induced birth defects. Advances in stem cell-based 
and other regenerative therapies could bring therapeutic benefits for neural defects associated with 
ethanol exposure. A recent study used neural stem cells to rescue neuronal cell death induced by 
prenatal alcohol exposure and showed potential therapeutic efficacy for memory and social recognition 
deficits in neonatal rats [111]. Using atellocollagen (purified collagen) to deliver the neural stem cells, 
these investigators provided a physical scaffold for the proliferating cells, which may potentiate their 
migration and reduce immune rejection. In addition to evaluating cell based therapies, these stem cell 
approaches can be used to evaluate abnormal cellular mechanisms associated with FASD. Medical 
treatments using fetal brain-derived NSCs or embryonic stem cells have important ethical issues, 
which must be fully explored. However, the potential benefit of advanced therapeutics warrants our 
efforts to help patients through additional FASD research, which may lead to targeted interventions 
that attenuate the numerous birth defects associated with prenatal alcohol exposure. 
Acknowledgements 
The studies in this review is supported by NIH AA016698 and P50 AA07611, and W.M. Keck 
foundation to FCZ, and NIH P50 AA07611 pilot funding to JAM. 
Conflict of Interest 
The authors declare no conflict of interest 
Brain Sci. 2013, 3 984 
 
 
References 
1. May, P.A.; Gossage, J.P.; Kalberg, W.O.; Robinson, L.K.; Buckley, D.; Manning, M.;  
Hoyme, H.E. Prevalence and epidemiologic characteristics of FASD from various research 
methods with an emphasis on recent in-school studies. Dev. Disabil. Res. Rev. 2009, 15,  
176–192. 
2. Moore, E.S.; Ward, R.E.; Jamison, P.L.; Morris, C.A.; Bader, P.I.; Hall, B.D. The subtle facial 
signs of prenatal exposure to alcohol: An anthropometric approach. J. Pediatr. 2001, 139,  
215–219. 
3. Moore, E.S.; Ward, R.E.; Wetherill, L.F.; Rogers, J.L.; Autti-Ramo, I.; Fagerlund, A.;  
Jacobson, S.W.; Robinson, L.K.; Hoyme, H.E.; Mattson, S.N.; Foroud, T. Unique facial features 
distinguish fetal alcohol syndrome patients and controls in diverse ethnic populations. Alcohol. 
Clin. Exp. Res. 2007, 31, 1707–1713. 
4. Webster, W.S.; Walsh, D.A.; Lipson, A.H.; McEwen, S.E. Teratogenesis after acute alcohol 
exposure in inbred and out-bred mice. Neurobehav. Toxicol. 1980, 2, 227–234 
5. Sulik, K.K. Genesis of alcohol-induced craniofacial dysmorphism. Exp. Biol. Med. (Maywood) 
2005, 230, 366–375. 
6. Sulik, K.K.; Cook, C.S.; Webster, W.S. Teratogens and craniofacial malformations: 
Relationships to cell death. Development 1988, 103, 213–231. 
7. Sulik, K.K.; Johnston, M.C.; Webb, M.A. Fetal alcohol syndrome: Embryogenesis in a mouse 
model. Science 1981, 214, 936–938. 
8. Blader, P.; Strahle, U. Ethanol impairs migration of the prechordal plate in the zebrafish embryo. 
Dev. Biol. 1998, 201, 185–201. 
9. Lipinski, R.J.; Hammond, P.; O’Leary-Moore, S.K.; Ament, J.J.; Pecevich, S.J.; Jiang, Y.; 
Budin, F.; Parnell, S.E.; Suttie, M.; Godin, E.A.; et al. Ethanol-induced face-brain 
dysmorphology patterns are correlative and exposure-stage dependent. PLoS One 2012,  
7, e43067. 
10. Anthony, B.; Vinci-Booher, S.; Wetherill, L.; Ward, R.; Goodlett, C.; Zhou, F.C.  
Alcohol-induced facial dysmorphology in C57BL/6 mouse models of fetal alcohol spectrum 
disorder. Alcohol 2010, 44, 659–671. 
11. Nakatsuji, N. Craniofacial malformation in Xenopus laevis tadpoles caused by the exposure of 
early embryos to ethanol. Teratology 1983, 28, 299–305. 
12. Pennington, S.N. Alcohol metabolism and fetal hypoplasia in chick brain. Alcohol 1988, 5,  
91–94. 
13. Roebuck, T.M.; Mattson, S.N.; Riley, E.P. A review of the neuroanatomical findings in children 
with fetal alcohol syndrome or prenatal exposure to alcohol. Alcohol. Clin. Exp. Res. 1998, 22, 
339–344. 
14. Coulter, C.L.; Leech, R.W.; Schaefer, G.B.; Scheithauer, B.W.; Brumback, R.A. Midline 
cerebral dysgenesis, dysfunction of the hypothalamic-pituitary axis, and fetal alcohol effects. 
Arch. Neurol. 1993, 50, 771–775. 
15. Lebel, C.; Roussotte, F.; Sowell, E.R. Imaging the impact of prenatal alcohol exposure on the 
structure of the developing human brain. Neuropsychol. Rev. 2011, 21, 102–118. 
Brain Sci. 2013, 3 985 
 
 
16. Zhou, D.; Lebel, C.; Lepage, C.; Rasmussen, C.; Evans, A.; Wyper, K.; Pei, J.; Andrew, G.; 
Massey, A.; Massey, D.; Beaulieu, C. Developmental cortical thinning in fetal alcohol spectrum 
disorders. NeuroImage 2011, 58, 16–25. 
17. Yang, Y.; Roussotte, F.; Kan, E.; Sulik, K.K.; Mattson, S.N.; Riley, E.P.; Jones, K.L.;  
Adnams, C.M.; May, P.A.; O’Connor, M.J.; et al. Abnormal cortical thickness alterations in fetal 
alcohol spectrum disorders and their relationships with facial dysmorphology. Cereb. Cortex 
2012, 22, 1170–1179. 
18. Yang, Y.; Phillips, O.R.; Kan, E.; Sulik, K.K.; Mattson, S.N.; Riley, E.P.; Jones, K.L.;  
Adnams, C.M.; May, P.A.; O’Connor, M.J.; et al. Callosal thickness reductions relate to facial 
dysmorphology in fetal alcohol spectrum disorders. Alcohol. Clin. Exp. Res. 2012, 36, 798–806. 
19. O’Leary-Moore, S.K.; Parnell, S.E.; Godin, E.A.; Dehart, D.B.; Ament, J.J.; Khan, A.A.; 
Johnson, G.A.; Styner, M.A.; Sulik, K.K. Magnetic resonance microscopy-based analyses of the 
brains of normal and ethanol-exposed fetal mice. Birth Defects Res. A Clin. Mol. Teratol. 2010, 
88, 953–964. 
20. O’Leary-Moore, S.K.; Parnell, S.E.; Lipinski, R.J.; Sulik, K.K. Magnetic resonance-based 
imaging in animal models of fetal alcohol spectrum disorder. Neuropsychol. Rev. 2011, 21,  
167–185. 
21. Parnell, S.E.; O’Leary-Moore, S.K.; Godin, E.A.; Dehart, D.B.; Johnson, B.W.;  
Allan Johnson, G.; Styner, M.A.; Sulik, K.K. Magnetic resonance microscopy defines  
ethanol-induced brain abnormalities in prenatal mice: Effects of acute insult on gestational day 8. 
Alcohol. Clin. Exp. Res. 2009, 33, 1001–1011. 
22. Godin, E.A.; O’Leary-Moore, S.K.; Khan, A.A.; Parnell, S.E.; Ament, J.J.; Dehart, D.B.; 
Johnson, B.W.; Allan Johnson, G.; Styner, M.A.; Sulik, K.K. Magnetic resonance microscopy 
defines ethanol-induced brain abnormalities in prenatal mice: Effects of acute insult on 
gestational day 7. Alcohol. Clin. Exp. Res. 2010, 34, 98–111. 
23. Pierce, D.R.; Williams, D.K.; Light, K.E. Purkinje cell vulnerability to developmental ethanol 
exposure in the rat cerebellum. Alcohol. Clin. Exp. Res. 1999, 23, 1650–1659. 
24. Ramadoss, J.; Lunde, E.R.; Chen, W.J.; West, J.R.; Cudd, T.A. Temporal vulnerability of fetal 
cerebellar Purkinje cells to chronic binge alcohol exposure: Ovine model. Alcohol. Clin. Exp. 
Res. 2007, 31, 1738–1745. 
25. Ramadoss, J.; Lunde, E.R.; Pina, K.B.; Chen, W.J.; Cudd, T.A. All three trimester binge alcohol 
exposure causes fetal cerebellar purkinje cell loss in the presence of maternal hypercapnea, 
acidemia, and normoxemia: Ovine model. Alcohol. Clin. Exp. Res. 2007, 31, 1252–1258. 
26. West, J.R.; Goodlett, C.R.; Bonthius, D.J.; Hamre, K.M.; Marcussen, B.L. Cell population 
depletion associated with fetal alcohol brain damage: Mechanisms of BAC-dependent cell loss. 
Alcohol. Clin. Exp. Res. 1990, 14, 813–818. 
27. Olney, J.W. Fetal alcohol syndrome at the cellular level. Addict. Biol. 2004, 9, 137–149. 
28. Sarmah, S.; Muralidharan, P.; Curtis, C.L.; McClintick, J.N.; Buente, B.B.; Holdgrafer, D.J.; 
Ogbeifun, O.; Olorungbounmi, O.C.; Patino, L.; Lucas, R.; et al. Ethanol exposure disrupts 
extraembryonic microtubule cytoskeleton and embryonic blastomere cell adhesion, producing 
epiboly and gastrulation defects. 2013, submitted for publication. 
Brain Sci. 2013, 3 986 
 
 
29. Church, M.W. Chronic in utero alcohol exposure affects auditory function in rats and in humans. 
Alcohol 1987, 4, 231–239. 
30. Cone-Wesson, B. Prenatal alcohol and cocaine exposure: Influences on cognition, speech, 
language, and hearing. J. Commun. Disord. 2005, 38, 279–302. 
31. Kotch, L.E.; Sulik, K.K. Patterns of ethanol-induced cell death in the developing nervous system 
of mice; neural fold states through the time of anterior neural tube closure. Int. J. Dev. Neurosci. 
1992, 10, 273–279. 
32. Liang, Y.; Wang, Z.M.; Qu, W.D. Evaluation of embryonic alcoholism from auditory  
event-related potential in fetal rats. Chin. Med. J. (Engl.) 2004, 117, 1422–1424. 
33. Eade, A.M.; Sheehe, P.R.; Youngentob, S.L. Ontogeny of the enhanced fetal-ethanol-induced 
behavioral and neurophysiologic olfactory response to ethanol odor. Alcohol. Clin. Exp. Res. 
2010, 34, 206–213. 
34. Youngentob, S.L.; Glendinning, J.I. Fetal ethanol exposure increases ethanol intake by making it 
smell and taste better. Proc. Natl. Acad. Sci. USA 2009, 106, 5359–5364. 
35. Bonthius, D.J.; Bonthius, N.E.; Napper, R.M.; West, J.R. Early postnatal alcohol exposure 
acutely and permanently reduces the number of granule cells and mitral cells in the rat olfactory 
bulb: A stereological study. J. Comp. Neurol. 1992, 324, 557–566. 
36. Akers, K.G.; Kushner, S.A.; Leslie, A.T.; Clarke, L.; van der Kooy, D.; Lerch, J.P.;  
Frankland, P.W. Fetal alcohol exposure leads to abnormal olfactory bulb development and 
impaired odor discrimination in adult mice. Mol. Brain 2011, 4, 29. 
37. Middleton, F.A.; Carrierfenster, K.; Mooney, S.M.; Youngentob, S.L. Gestational ethanol 
exposure alters the behavioral response to ethanol odor and the expression of neurotransmission 
genes in the olfactory bulb of adolescent rats. Brain Res. 2009, 1252, 105–116. 
38. Stromland, K.; Pinazo-Duran, M.D. Ophthalmic involvement in the fetal alcohol syndrome: 
Clinical and animal model studies. Alcohol Alcohol. 2002, 37, 2–8. 
39. Hug, T.E.; Fitzgerald, K.M.; Cibis, G.W. Clinical and electroretinographic findings in fetal 
alcohol syndrome. J. AAPOS 2000, 4, 200–204. 
40. Katz, L.M.; Fox, D.A. Prenatal ethanol exposure alters scotopic and photopic components of 
adult rat electroretinograms. Invest. Ophthalmol. Vis. Sci. 1991, 32, 2861–2872. 
41. Matsui, J.I.; Egana, A.L.; Sponholtz, T.R.; Adolph, A.R.; Dowling, J.E. Effects of ethanol on 
photoreceptors and visual function in developing zebrafish. Invest. Ophthalmol. Vis. Sci. 2006, 
47, 4589–4597. 
42. Bilotta, J.; Saszik, S.; Givin, C.M.; Hardesty, H.R.; Sutherland, S.E. Effects of embryonic 
exposure to ethanol on zebrafish visual function. Neurotoxicol. Teratol. 2002, 24, 759–766. 
43. Arenzana, F.J.; Carvan, M.J., III; Aijon, J.; Sanchez-Gonzalez, R.; Arevalo, R.; Porteros, A. 
Teratogenic effects of ethanol exposure on zebrafish visual system development. Neurotoxicol. 
Teratol. 2006, 28, 342–348. 
44. Yelin, R.; Kot, H.; Yelin, D.; Fainsod, A. Early molecular effects of ethanol during vertebrate 
embryogenesis. Differentiation 2007, 75, 393–403. 
45. Kashyap, B.; Frederickson, L.C.; Stenkamp, D.L. Mechanisms for persistent microphthalmia 
following ethanol exposure during retinal neurogenesis in zebrafish embryos. Vis. Neurosci. 
2007, 24, 409–421. 
Brain Sci. 2013, 3 987 
 
 
46. Deng, J.X.; Liu, X.; Zang, J.F.; Huang, H.E.; Xi, Y.; Zheng, H.; Yao, H.L.; Yu, D.M.; Deng, J.B. 
The effects of prenatal alcohol exposure on the developmental retina of mice. Alcohol Alcohol. 
2012, 47, 380–385. 
47. Cartwright, M.M.; Smith, S.M. Stage-dependent effects of ethanol on cranial neural crest cell 
development: Partial basis for the phenotypic variations observed in fetal alcohol syndrome. 
Alcohol. Clin. Exp. Res. 1995, 19, 1454–1462. 
48. Cartwright, M.M.; Tessmer, L.L.; Smith, S.M. Ethanol-induced neural crest apoptosis is 
coincident with their endogenous death, but is mechanistically distinct. Alcohol. Clin. Exp. Res. 
1998, 22, 142–149. 
49. Ahlgren, S.C.; Thakur, V.; Bronner-Fraser, M. Sonic hedgehog rescues cranial neural crest from 
cell death induced by ethanol exposure. Proc. Natl. Acad. Sci. USA 2002, 99, 10476–10481. 
50. Smith, S.M. Alcohol-induced cell death in the embryo. Alcohol Health Res. World 1997, 21, 
287–297. 
51. Bronner-Fraser, M. Neural crest cell formation and migration in the developing embryo. FASEB 
J. 1994, 8, 699–706. 
52. Knecht, A.K.; Bronner-Fraser, M. Induction of the neural crest: A multigene process. Nat. Rev. 
Genet. 2002, 3, 453–461. 
53. Lieber, C.S. Relationships between nutrition, alcohol use, and liver disease. Alcohol Res. Health 
2003, 27, 220–231. 
54. Durston, A.J.; Timmermans, J.P.; Hage, W.J.; Hendriks, H.F.; de Vries, N.J.; Heideveld, M.; 
Nieuwkoop, P.D. Retinoic acid causes an anteroposterior transformation in the developing 
central nervous system. Nature 1989, 340, 140–144. 
55. Mezey, E.; Holt, P.R. The inhibitory effect of ethanol on retinol oxidation by human liver and 
cattle retina. Exp. Mol. Pathol. 1971, 15, 148–156. 
56. Duester, G. A hypothetical mechanism for fetal alcohol syndrome involving ethanol inhibition of 
retinoic acid synthesis at the alcohol dehydrogenase step. Alcohol. Clin. Exp. Res. 1991, 15,  
568–572. 
57. Keir, W.J. Inhibition of retinoic acid synthesis and its implications in fetal alcohol syndrome. 
Alcohol. Clin. Exp. Res. 1991, 15, 560–564. 
58. Marrs, J.A.; Clendenon, S.G.; Ratcliffe, D.R.; Fielding, S.M.; Liu, Q.; Bosron, W.F. Zebrafish 
fetal alcohol syndrome model: Effects of ethanol are rescued by retinoic acid supplement. 
Alcohol 2010, 44, 707–715. 
59. Kot-Leibovich, H.; Fainsod, A. Ethanol induces embryonic malformations by competing for 
retinaldehyde dehydrogenase activity during vertebrate gastrulation. Dis. Model. Mech. 2009, 2, 
295–305. 
60. Yelin, R.; Schyr, R.B.; Kot, H.; Zins, S.; Frumkin, A.; Pillemer, G.; Fainsod, A. Ethanol 
exposure affects gene expression in the embryonic organizer and reduces retinoic acid levels. 
Dev. Biol. 2005, 279, 193–204. 
61. Sarmah, S.; Marrs, J.A. Complex cardiac defects after ethanol exposure during discrete 
cardiogenic events in zebrafish: Prevention with folic acid. 2013, submitted for publication. 
Brain Sci. 2013, 3 988 
 
 
62. Kashyap, B.; Frey, R.A.; Stenkamp, D.L. Ethanol-induced microphthalmia is not mediated by 
changes in retinoic acid or sonic hedgehog signaling during retinal neurogenesis. Alcohol. Clin. 
Exp. Res. 2011, 35, 1644–1661. 
63. Barak, A.J.; Beckenhauer, H.C.; Tuma, D.J.; Badakhsh, S. Effects of prolonged ethanol feeding 
on methionine metabolism in rat liver. Biochem. Cell Biol. 1987, 65, 230–233. 
64. Mason, J.B.; Choi, S.W. Effects of alcohol on folate metabolism: Implications for 
carcinogenesis. Alcohol 2005, 35, 235–241. 
65. Barak, A.J.; Beckenhauer, H.C.; Junnila, M.; Tuma, D.J. Dietary betaine promotes generation of 
hepatic S-adenosylmethionine and protects the liver from ethanol-induced fatty infiltration. 
Alcohol. Clin. Exp. Res. 1993, 17, 552–555. 
66. Beaudin, A.E.; Abarinov, E.V.; Noden, D.M.; Perry, C.A.; Chu, S.; Stabler, S.P.; Allen, R.H.; 
Stover, P.J. Shmt1 and de novo thymidylate biosynthesis underlie folate-responsive neural tube 
defects in mice. Am. J. Clin. Nutr. 2011, 93, 789–798. 
67. Hutson, J.R.; Stade, B.; Lehotay, D.C.; Collier, C.P.; Kapur, B.M. Folic acid transport to the 
human fetus is decreased in pregnancies with chronic alcohol exposure. PLoS One 2012, 7, 
e38057. 
68. Wang, L.L.; Zhang, Z.; Li, Q.; Yang, R.; Pei, X.; Xu, Y.; Wang, J.; Zhou, S.F.; Li, Y. Ethanol 
exposure induces differential microRNA and target gene expression and teratogenic effects 
which can be suppressed by folic acid supplementation. Hum. Reprod. 2009, 24, 562–579. 
69. Serrano, M.; Han, M.; Brinez, P.; Linask, K.K. Fetal alcohol syndrome: Cardiac birth defects in 
mice and prevention with folate. Am. J. Obstet. Gynecol. 2010, 203, 75 e77–75 e15. 
70. Fisher, M.C.; Zeisel, S.H.; Mar, M.H.; Sadler, T.W. Perturbations in choline metabolism cause 
neural tube defects in mouse embryos in vitro. FASEB J. 2002, 16, 619–621. 
71. Thomas, J.D.; Abou, E.J.; Dominguez, H.D. Prenatal choline supplementation mitigates the 
adverse effects of prenatal alcohol exposure on development in rats. Neurotoxicol. Teratol. 2009, 
31, 303–311. 
72. Thomas, J.D.; Idrus, N.M.; Monk, B.R.; Dominguez, H.D. Prenatal choline supplementation 
mitigates behavioral alterations associated with prenatal alcohol exposure in rats. Birth Defects 
Res. A Clin. Mol. Teratol. 2010, 88, 827–837. 
73. Monk, B.R.; Leslie, F.M.; Thomas, J.D. The effects of perinatal choline supplementation on 
hippocampal cholinergic development in rats exposed to alcohol during the brain growth spurt. 
Hippocampus 2012, 22, 1750–1757. 
74. Otero, N.K.; Thomas, J.D.; Saski, C.A.; Xia, X.; Kelly, S.J. Choline supplementation and DNA 
methylation in the hippocampus and prefrontal cortex of rats exposed to alcohol during 
development. Alcohol. Clin. Exp. Res. 2012, 36, 1701–1709. 
75. Miller, R.R., Jr.; Olson, B.M.; Rorick, N.; Wittingen, A.L.; Bullock, M. Embryonic exposure to 
exogenous alpha- and gamma-tocopherol partially attenuates ethanol-induced changes in brain 
morphology and brain membrane fatty acid composition. Nutr. Neurosci. 2003, 6, 201–212. 
76. Mitchell, J.J.; Paiva, M.; Heaton, M.B. The antioxidants vitamin E and beta-carotene protect 
against ethanol-induced neurotoxicity in embryonic rat hippocampal cultures. Alcohol 1999, 17, 
163–168. 
Brain Sci. 2013, 3 989 
 
 
77. Siler-Marsiglio, K.I.; Shaw, G.; Heaton, M.B. Pycnogenol and vitamin E inhibit ethanol-induced 
apoptosis in rat cerebellar granule cells. J. Neurobiol. 2004, 59, 261–271. 
78. Miller, G.W.; Labut, E.M.; Lebold, K.M.; Floeter, A.; Tanguay, R.L.; Traber, M.G. Zebrafish 
(Danio rerio) fed vitamin E-deficient diets produce embryos with increased morphologic 
abnormalities and mortality. J. Nutr. Biochem. 2012, 23, 478–486. 
79. Heaton, M.B.; Paiva, M.; Siler-Marsiglio, K. Ethanol influences on Bax translocation, 
mitochondrial membrane potential, and reactive oxygen species generation are modulated by 
vitamin E and brain-derived neurotrophic factor. Alcohol. Clin. Exp. Res. 2011, 35, 1122–1133. 
80. Brocardo, P.S.; Gil-Mohapel, J.; Christie, B.R. The role of oxidative stress in fetal alcohol 
spectrum disorders. Brain Res. Rev. 2011, 67, 209–225. 
81. Peng, Y.; Yang, P.H.; Guo, Y.; Ng, S.S.; Liu, J.; Fung, P.C.; Tay, D.; Ge, J.; He, M.L.;  
Kung, H.F.; Lin, M.C. Catalase and peroxiredoxin 5 protect Xenopus embryos against  
alcohol-induced ocular anomalies. Invest. Ophthalmol. Vis. Sci. 2004, 45, 23–29. 
82. Antonio, A.M.; Gillespie, R.A.; Druse-Manteuffel, M.J. Effects of lipoic acid on antiapoptotic 
genes in control and ethanol-treated fetal rhombencephalic neurons. Brain Res 2011, 1383,  
13–21. 
83. Parnell, S.E.; Sulik, K.K.; Dehart, D.B.; Chen, S.Y. Reduction of ethanol-induced ocular 
abnormalities in mice through dietary administration of N-acetylcysteine. Alcohol 2010, 44,  
699–705. 
84. Peng, Y.; Kwok, K.H.; Yang, P.H.; Ng, S.S.; Liu, J.; Wong, O.G.; He, M.L.; Kung, H.F.;  
Lin, M.C. Ascorbic acid inhibits ROS production, NF-kappa B activation and prevents  
ethanol-induced growth retardation and microencephaly. Neuropharmacology 2005, 48,  
426–434. 
85. Dong, J.; Sulik, K.K.; Chen, S.Y. Nrf2-mediated transcriptional induction of antioxidant 
response in mouse embryos exposed to ethanol in vivo: Implications for the prevention of fetal 
alcohol spectrum disorders. Antioxid. Redox Signal. 2008, 10, 2023–2033. 
86. Kane, C.J.; Phelan, K.D.; Han, L.; Smith, R.R.; Xie, J.; Douglas, J.C.; Drew, P.D. Protection of 
neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by 
peroxisome proliferator-activated receptor-gamma agonists. Brain Behav. Immun. 2011, 25, 
S137–S145. 
87. Wang, G.; Bieberich, E. Prenatal alcohol exposure triggers ceramide-induced apoptosis in neural 
crest-derived tissues concurrent with defective cranial development. Cell Death Dis. 2010,  
1, e46. 
88. Flentke, G.R.; Garic, A.; Amberger, E.; Hernandez, M.; Smith, S.M. Calcium-mediated 
repression of beta-catenin and its transcriptional signaling mediates neural crest cell death in  
an avian model of fetal alcohol syndrome. Birth Defects Res. A Clin. Mol. Teratol. 2011, 91,  
591–602. 
89. Garic-Stankovic, A.; Hernandez, M.R.; Chiang, P.J.; Debelak-Kragtorp, K.A.; Flentke, G.R.; 
Armant, D.R.; Smith, S.M. Ethanol triggers neural crest apoptosis through the selective 
activation of a pertussis toxin-sensitive G protein and a phospholipase Cbeta-dependent Ca2+ 
transient. Alcohol. Clin. Exp. Res. 2005, 29, 1237–1246. 
Brain Sci. 2013, 3 990 
 
 
90. Vangipuram, S.D.; Grever, W.E.; Parker, G.C.; Lyman, W.D. Ethanol increases fetal human 
neurosphere size and alters adhesion molecule gene expression. Alcohol. Clin. Exp. Res. 2008, 
32, 339–347. 
91. Garic, A.; Flentke, G.R.; Amberger, E.; Hernandez, M.; Smith, S.M. CaMKII activation is  
a novel effector of alcohol’s neurotoxicity in neural crest stem/progenitor cells. J. Neurochem. 
2011, 118, 646–657. 
92. Luo, J. Lithium-mediated protection against ethanol neurotoxicity. Front. Neurosci. 2010, 4, 41. 
93. Zhou, F.C. DNA methylation program during development. Front. Biol. 2012, 485–494. 
94. Mill, J.; Petronis, A. Pre- and peri-natal environmental risks for attention-deficit hyperactivity 
disorder (ADHD): The potential role of epigenetic processes in mediating susceptibility. J. Child 
Psychol. Psychiatry 2008, 49, 1020–1030. 
95. Resendiz, M.; Chen, Y.; Ozturk, N.C.; Zhou, F.C. Epigenetic medicine and fetal alcohol 
spectrum disorders. Epigenomics 2013, 5, 73–86. 
96. Haycock, P.C. Fetal alcohol spectrum disorders: The epigenetic perspective. Biol. Reprod. 2009, 
81, 607–617. 
97. Garro, A.J.; McBeth, D.L.; Lima, V.; Lieber, C.S. Ethanol consumption inhibits fetal DNA 
methylation in mice: Implications for the fetal alcohol syndrome. Alcohol. Clin. Exp. Res. 1991, 
15, 395–398. 
98. Kaminen-Ahola, N.; Ahola, A.; Maga, M.; Mallitt, K.A.; Fahey, P.; Cox, T.C.; Whitelaw, E.; 
Chong, S. Maternal ethanol consumption alters the epigenotype and the phenotype of offspring in 
a mouse model. PLoS Genet. 2010, 6, e1000811. 
99. Bonsch, D.; Lenz, B.; Fiszer, R.; Frieling, H.; Kornhuber, J.; Bleich, S. Lowered DNA 
methyltransferase (DNMT-3b) mRNA expression is associated with genomic DNA 
hypermethylation in patients with chronic alcoholism. J. Neural. Transm. 2006, 113, 1299–1304. 
100. Zhou, F.C.; Balaraman, Y.; Teng, M.; Liu, Y.; Singh, R.P.; Nephew, K.P. Alcohol alters DNA 
methylation patterns and inhibits neural stem cell differentiation. Alcohol. Clin. Exp. Res. 2011, 
35, 735–746. 
101. Liu, Y.; Balaraman, Y.; Wang, G.; Nephew, K.P.; Zhou, F.C. Alcohol exposure alters DNA 
methylation profiles in mouse embryos at early neurulation. Epigenetics 2009, 4, 500–511. 
102. Chen, Y.; Ozturk, N.C.; Zhou, F.C. DNA methylation program in developing hippocampus and 
its alteration by alcohol. PLoS One 2013, 8, e60503. 
103. Zhou, F.C.; Chen, Y.; Love, A. Cellular DNA methylation program during neurulation and its 
alteration by alcohol exposure. Birth Defects Res. A Clin. Mol. Teratol. 2011, 91, 703–715. 
104. Singh, R.P.; Shiue, K.; Schomberg, D.; Zhou, F.C. Cellular epigenetic modifications of neural 
stem cell differentiation. Cell Transplant. 2009, 18, 1197–1211. 
105. Subbanna, S.; Shivakumar, M.; Umapathy, N.S.; Saito, M.; Mohan, P.S.; Kumar, A.;  
Nixon, R.A.; Verin, A.D.; Psychoyos, D.; Basavarajappa, B.S. G9a-mediated histone 
methylation regulates ethanol-induced neurodegeneration in the neonatal mouse brain. 
Neurobiol. Dis. 2013, 54, 475–485. 
  
Brain Sci. 2013, 3 991 
 
 
106. Bekdash, R.A.; Zhang, C.; Sarkar, D.K. Gestational choline supplementation normalized fetal 
alcohol-induced alterations in histone modifications, DNA methylation, and proopiomelanocortin 
(POMC) gene expression in beta-endorphin-producing POMC neurons of the hypothalamus. 
Alcohol. Clin. Exp. Res. 2013, doi:10.1111/acer.12082. 
107. Mercer, T.R.; Dinger, M.E.; Mattick, J.S. Long non-coding RNAs: Insights into functions. Nat. 
Rev. Genet. 2009, 10, 155–159. 
108. Wang, G.; Wang, X.; Wang, Y.; Yang, J.Y.; Li, L.; Nephew, K.P.; Edenberg, H.J.; Zhou, F.C.; 
Liu, Y. Identification of transcription factor and microRNA binding sites in responsible to fetal 
alcohol syndrome. BMC Genomics 2008, 9, S19. 
109. Sathyan, P.; Golden, H.B.; Miranda, R.C. Competing interactions between micro-RNAs 
determine neural progenitor survival and proliferation after ethanol exposure: Evidence from an 
ex vivo model of the fetal cerebral cortical neuroepithelium. J. Neurosci. 2007, 27, 8546–8557. 
110. Soares, A.R.; Pereira, P.M.; Ferreira, V.; Reverendo, M.; Simoes, J.; Bezerra, A.R.; Moura, G.R.; 
Santos, M.A. Ethanol exposure induces upregulation of specific microRNAs in zebrafish 
embryos. Toxicol. Sci. 2012, 127, 18–28. 
111. Shirasaka, T.; Hashimoto, E.; Ukai, W.; Yoshinaga, T.; Ishii, T.; Tateno, M.; Saito, T. Stem cell 
therapy: Social recognition recovery in a FASD model. Transl. Psychiatry 2012, 2, e188. 
© 2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
